Global 
Australia 
België 
Deutschland 
España 
France 
Ireland 
Italia 
Luxembourg 
Nederland 
Österreich 
Portugal 
Россия 
Schweiz 
United Kingdom 
Dr. Falk Pharma – Innovation drives everything
As a research-based family business with global presence, we focus on the development and distribution of innovative medicines that improve patients’ health and well-being. For over 60 years.
Our focus: To enable relief, well-being, more ease of movement and confidence in everyday situations for millions of people with inflammatory bowel disease as well as digestive and metabolic problems. With the best possible therapies.
Falk Foundation provides a platform for experts in the fields of gastroenterology and hepatology to meet and communicate with one another.
Register for FalkPlus and access the expert education, events and resources for the management of digestive and metabolic diseases.
Access to expert education, events and resources for digestive and metabolic diseases is limited. It’s challenging to stay on top of the continual advancements in this field so we’ve developed the Dr. Falk Pharma way.
Become part of the Falk Community for HCPs
Access Falk Events, Education and Resources
Provide additional support to your patients
Products & Treatments
Innovative and reliable treatments for gastrointestinal and metabolic diseases
Inflammatory Bowel Disease
Inflammatory bowel disease (IBD) is a term mainly used to describe two conditions, ulcerative colitis and Crohn’s disease. Microscopic colitis is another type of IBD and more people have been getting diagnosed over the past few decades. These are all chronic life long conditions that involve inflammation of the gastrointestinal tract.
Liver Diseases
The incidence of liver diseases in the developed world has increased significantly over the past decades. Dr. Falk Pharma focuses on autoimmune liver diseases such as Primary Biliary Cholangitis (PBC), Autoimmune Hepatitis (AIH) and Primary Sclerosing Cholangitis (PSC). These diseases have chronic clinical courses and if left untreated can lead to serious consequences such as liver cirrhosis, liver cancer, liver failure and death.
Eosinophilic Oesophagitis (EoE)
EoE is a chronic (long term) progressive inflammatory disease which affects the lining of the oesophagus. Originally referred to as asthma of the oesophagus, EoE is thought to be triggered by an allergic response, usually to food but possibly also to environmental or other factors.
THE FALK COMMUNITY
We believe that by creating a strong community. Together we know more. Together we do more.
Join our community and gain access to:
- Live educational events
- Product information
- Education
- Resources
- Latest news
- Treatments
Your events in one place
Available on your computer, tablet and mobile.
